These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3532865)

  • 1. On-line differential pulse polarographic detection of carboplatin in biological samples after chromatographic separation.
    Elferink F; van der Vijgh WJ; Pinedo HM
    Anal Chem; 1986 Sep; 58(11):2293-6. PubMed ID: 3532865
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of antitumour [1,1-bis(aminomethyl)cyclohexane]platinum(II) complexes derived from spiroplatin by high-performance liquid chromatography with differential pulse amperometric detection.
    Elferink F; van der Vijgh WJ; Pinedo HM
    J Chromatogr; 1985 Mar; 320(2):379-92. PubMed ID: 4030937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine.
    Gaver RC; Deeb G
    Cancer Chemother Pharmacol; 1986; 16(3):201-6. PubMed ID: 3516429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of carboplatin in canine plasma by liquid chromatography with ultraviolet-visible detection and confirmation by atomic absorption spectroscopy.
    Tyczkowska K; Page RL; Riviere JE
    J Chromatogr; 1990 May; 527(2):447-53. PubMed ID: 2201694
    [No Abstract]   [Full Text] [Related]  

  • 5. The stability of carboplatin in ambulatory continuous infusion regimes.
    Sewell GJ; Riley CM; Rowland CG
    J Clin Pharm Ther; 1987 Dec; 12(6):427-32. PubMed ID: 3326888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive postcolumn derivatization/UV detection system for HPLC determination of antitumor divalent and quadrivalent platinum complexes.
    Kizu R; Yamamoto T; Yokoyama T; Tanaka M; Miyazaki M
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):108-14. PubMed ID: 7895301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of cisplatin formation in carboplatin admixtures.
    Perrone RK; Kaplan MA; Bogardus JB
    Am J Hosp Pharm; 1989 Feb; 46(2):258-9. PubMed ID: 2653024
    [No Abstract]   [Full Text] [Related]  

  • 8. Liquid chromatographic procedure for the quantitative analysis of carboplatin in beagle dog plasma ultrafiltrate.
    Duncan GF; Faulkner HC; Farmen RH; Pittman KA
    J Pharm Sci; 1988 Mar; 77(3):273-6. PubMed ID: 3286860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control of pharmaceutical formulations containing cisplatin, carboplatin, and oxaliplatin by micellar and microemulsion electrokinetic chromatography (MEKC, MEEKC).
    Nussbaumer S; Fleury-Souverain S; Schappler J; Rudaz S; Veuthey JL; Bonnabry P
    J Pharm Biomed Anal; 2011 May; 55(2):253-8. PubMed ID: 21330090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination methods for the anticancer drug dicycloplatin, a supramolecule assembled through hydrogen bonding.
    Yang X; Zheng J; Song Q; Xie F; Tang J; Chen J; Wu J; Li C; Cui W; Tang Y; Xie J; Zheng J
    Analyst; 2015 Apr; 140(8):2704-12. PubMed ID: 25686082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
    Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
    Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platinum derivatives].
    Sasaki Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():452-5. PubMed ID: 15658361
    [No Abstract]   [Full Text] [Related]  

  • 13. New techniques in the pharmacokinetic analysis of cancer drugs. II. The ultratrace determination of platinum in biological samples by inductively coupled plasma-mass spectrometry.
    McKay K
    Cancer Surv; 1993; 17():407-14. PubMed ID: 8137350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of platinum-containing drugs in human plasma by liquid chromatography with reductive electrochemical detection.
    Parsons PJ; Morrison PF; LeRoy AF
    J Chromatogr; 1987 Jan; 385():323-35. PubMed ID: 3558589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of carboplatin.
    Van Echo DA; Egorin MJ; Aisner J
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):1-6. PubMed ID: 2655093
    [No Abstract]   [Full Text] [Related]  

  • 16. Capillary liquid chromatography with UV detection using N,N-diethyl dithiocarbamate for determining platinum-based antitumor drugs in plasma.
    Otsuki Y; Kotani A; Kusu F
    Chem Pharm Bull (Tokyo); 2012; 60(5):665-9. PubMed ID: 22689405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry.
    Zhang W; Seymour L; Chen EX
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):277-82. PubMed ID: 19026601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of ethylenediamineplatinum(II) malonate in infusion fluids, human plasma and urine by high-performance liquid chromatography.
    van der Vijgh WJ; Elferink F; Postma GJ; Vermorken JB; Pinedo HM
    J Chromatogr; 1984 Oct; 310(2):335-42. PubMed ID: 6511851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of a novel platinum anticancer compound HJ5 by high performance liquid chromatography].
    Liu Y; He J; Liu ZD; Chen XZ; Liu WP
    Se Pu; 2002 Jul; 20(4):345-7. PubMed ID: 12541919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platinum derivatives].
    Sasaki Y
    Nihon Rinsho; 1999 Sep; 57 Suppl():425-7. PubMed ID: 10543144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.